60 DEGREES PHARMACEUTICALS, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
60 Degrees Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2023 to Q3 2024.
  • 60 Degrees Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $669K, a 21.8% increase year-over-year.
  • 60 Degrees Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $949K.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $669K +$120K +21.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $2.75M +$2.47M +888% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $867K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q3 2023 $549K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $279K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.